JOURNAL OF HEPATOLOGY

Scope & Guideline

Leading the Way in Hepatic Health Discoveries

Introduction

Delve into the academic richness of JOURNAL OF HEPATOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0168-8278
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1985 to 2024
AbbreviationJ HEPATOL / J. Hepatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The JOURNAL OF HEPATOLOGY is dedicated to advancing the understanding of liver diseases through innovative research and clinical studies. Its primary focus encompasses a variety of aspects related to hepatology, including diagnostics, treatment, and the underlying mechanisms of liver conditions.
  1. Clinical Research in Hepatology:
    The journal emphasizes clinical studies that provide insights into the diagnosis, treatment, and management of liver diseases, particularly chronic conditions such as hepatitis B and C, cirrhosis, and hepatocellular carcinoma.
  2. Biomarker Discovery and Validation:
    A significant focus is on identifying and validating biomarkers for liver diseases, which can aid in early diagnosis, prognosis, and monitoring treatment responses.
  3. Pathophysiology of Liver Diseases:
    The journal publishes research exploring the underlying biological mechanisms and pathophysiological changes associated with various liver diseases, contributing to a deeper understanding of disease progression.
  4. Noninvasive Diagnostic Techniques:
    There is a consistent emphasis on developing and evaluating noninvasive tools for liver assessment, such as imaging techniques and serum biomarkers, to improve patient management.
  5. Public Health and Epidemiology:
    The journal also covers studies addressing the epidemiology of liver diseases, health policies, and educational programs aimed at improving prevention and treatment outcomes in diverse populations.
Recent publications in the JOURNAL OF HEPATOLOGY reveal emerging themes that highlight new challenges and advancements in the field, reflecting shifts in research focus and clinical practice.
  1. Nonalcoholic Fatty Liver Disease (NAFLD) and Metabolic Disorders:
    There is an increasing emphasis on NAFLD, particularly its progression to metabolic-associated steatohepatitis, indicating a growing recognition of the need to address liver disease within the context of metabolic health.
  2. Impact of Aging on Liver Disease Outcomes:
    Research focusing on the outcomes of liver diseases in older populations is trending, as clinicians seek to understand how age-related factors influence disease progression and treatment responses.
  3. Integration of Technology in Liver Disease Management:
    Emerging studies exploring the use of technology, including telemedicine and mobile health applications, for the management of liver diseases signify a shift towards more accessible healthcare solutions.
  4. Multi-morbidity in Liver Disease Patients:
    The intersection of liver disease with other chronic conditions, such as HIV and renal failure, is gaining attention, highlighting the complexity of managing patients with multiple health issues.
  5. Education and Awareness Programs:
    There is a growing trend towards research exploring the effectiveness of educational initiatives targeting healthcare professionals and the public to improve awareness and prevention of liver diseases.

Declining or Waning

While the JOURNAL OF HEPATOLOGY continues to explore a wide range of topics, certain themes appear to be losing prominence as research focus shifts towards more pressing areas of hepatology.
  1. Traditional Invasive Procedures for Liver Assessment:
    There has been a noticeable decline in studies focusing on traditional invasive techniques, such as liver biopsies, as the field increasingly prioritizes noninvasive methods for evaluating liver conditions.
  2. Historical Case Studies:
    The journal has reduced its publication of historical case studies or retrospectives that do not contribute new insights or advancements in the understanding of liver diseases.
  3. General Hepatology Reviews:
    There seems to be a waning interest in broad review articles that summarize existing knowledge without proposing new research directions or insights into future challenges in hepatology.

Similar Journals

HEPATOLOGY

Advancing liver research for a healthier tomorrow.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0270-9139Frequency: 12 issues/year

HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.

International Journal of Hepatology

Exploring the frontiers of liver disease management.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

JGH Open

Empowering the Future of Gastrointestinal Medicine
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Canadian Journal of Gastroenterology and Hepatology

Empowering Healthcare through Open Access Research
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

Hepatology Forum

Elevating hepatology insights for practitioners and scholars.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.

Korean Journal of Gastroenterology

Exploring Innovations in Gastroenterology
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Canadian Liver Journal

Unveiling Insights, Transforming Liver Care.
Publisher: UNIV TORONTO PRESS INCISSN: Frequency: 4 issues/year

Canadian Liver Journal, published by University of Toronto Press Inc., offers a dedicated platform for the dissemination of cutting-edge research in the field of Hepatology. With an E-ISSN of 2561-4444, this journal plays a pivotal role in advancing knowledge related to liver diseases and therapies, currently ranked in the 3rd quartile (Q3) for the 2023 category in Hepatology—a reflection of its growing influence in the biomedical research community. The journal, which has been in circulation since 2018 and sets its sights on contributing valuable insights until 2024, aims to engage researchers, clinicians, and students alike by providing a rigorous peer-reviewed environment for sharing findings, case studies, and reviews pertinent to liver health. Through its commitment to excellence and scholarly impact, the Canadian Liver Journal serves as an essential resource for those dedicated to combating liver diseases and enhancing patient care.

Annals of Hepatology

Connecting researchers and clinicians in the quest for liver health.
Publisher: ELSEVIER ESPANAISSN: 1665-2681Frequency: 6 issues/year

Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.

Translational Gastroenterology and Hepatology

Transforming Laboratory Insights into Clinical Excellence.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Clinics in Liver Disease

Fostering knowledge and innovation in liver disease research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.